Provectus Biopharmaceuticals I shares owned by Academy Capital Management
Quarter-by-quarter ownership of Provectus Biopharmaceuticals I (PVCT) shares owned by Academy Capital Management
from 13F filings
Historical chart of Academy Capital Management investment in Provectus Biopharmaceuticals I
Tip: Access up to 7 years of quarterly data
All positions including Provectus Biopharmaceuticals I held by Academy Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Provectus Biopharmaceuticals I by Academy Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.8k | 20k | 0.09 |
| 2025-06-30 | $1.5k | 20k | 0.07 |
| 2025-03-31 | $2.0k | 20k | 0.10 |
| 2024-12-31 | $2.4k | 20k | 0.12 |
| 2024-09-30 | $2.0k | 20k | 0.10 |
| 2024-06-30 | $2.5k | 20k | 0.13 |
| 2024-03-31 | $3.7k | 20k | 0.18 |
| 2023-09-30 | $1.7k | 20k | 0.08 |
| 2023-06-30 | $2.3k | 20k | 0.11 |
| 2023-03-31 | $3.0k | 20k | 0.15 |
| 2022-12-31 | $2.2k | 20k | 0.11 |
| 2022-09-30 | $1.0k | 20k | 0.05 |
| 2022-06-30 | $1.0k | 20k | 0.05 |
| 2022-03-31 | $1.0k | 20k | 0.05 |
| 2021-12-31 | $1.0k | 20k | 0.05 |
| 2021-09-30 | $1.0k | 20k | 0.05 |
| 2021-06-30 | $1.0k | 20k | 0.05 |
| 2021-03-31 | $1.0k | 20k | 0.05 |
| 2020-12-31 | $1.0k | 20k | 0.05 |
| 2020-09-30 | $1.0k | 20k | 0.05 |
| 2020-03-31 | $1.0k | 20k | 0.05 |
| 2019-12-31 | $1.0k | 20k | 0.05 |
| 2019-09-30 | $1.0k | 20k | 0.05 |
| 2019-06-30 | $1.0k | 20k | 0.05 |
| 2019-03-31 | $1.0k | 20k | 0.05 |
| 2018-12-31 | $1.0k | 20k | 0.05 |
| 2018-09-30 | $1.0k | 20k | 0.05 |
| 2018-03-31 | $1.0k | 20k | 0.05 |
| 2017-12-31 | $1.0k | 20k | 0.05 |
| 2017-09-30 | $0 | 20k | 0.00 |
| 2016-09-30 | $1.0k | 20k | 0.05 |
| 2016-06-30 | $6.0k | 20k | 0.30 |
| 2016-03-31 | $7.0k | 20k | 0.35 |
| 2014-06-30 | $17k | 20k | 0.85 |
| 2014-03-31 | $49k | 20k | 2.45 |
More positions owned by Academy Capital Management
View all positions for Academy Capital Management
Top funds holding Provectus Biopharmaceuticals I
View all funds holding Provectus Biopharmaceuticals I